Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: RNA transport (mmu03013)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
1700009N
14Rik
KLA  ATP  ATP+KLA
 NM_001081095 RIKEN cDNA 1700009N14 gene (1700009N14Rik), mRNA [NM_001081095] KLA .94 .99 1.04 1.06 1.04 1.00 .93
ATP 1.03 1.12 1.03 1.00 .89 1.04 .99
KLA/ATP .98 .94 1.05 1.03 .98 .95 1.02
2810432D
09Rik
KLA  ATP  ATP+KLA
 NM_027278 RIKEN cDNA 2810432D09 gene (2810432D09Rik), mRNA [NM_027278] KLA .83 .87 .89 1.05 .99 .91 .91
ATP 1.02 1.00 .94 .84 .75 1.51 1.42
KLA/ATP .79 .85 .93 .82 .92 1.65 1.51
4930444G
20Rik
KLA  ATP  ATP+KLA
 NM_053264 RIKEN cDNA 4930444G20 gene (4930444G20Rik), mRNA [NM_053264] KLA 1.01 1.00 .98 .92 .90 .97 1.01
ATP 1.06 1.03 .96 1.08 .99 1.00 .98
KLA/ATP 1.11 1.04 1.00 1.05 .92 .97 1.04
Aaas
KLA  ATP  ATP+KLA
 AK051635 12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130061E05 product:unclassifiable, full insert sequence [AK051635] KLA .97 .91 .90 .95 .91 .93 .80
ATP 1.02 1.04 .91 .83 .93 .88 .89
KLA/ATP .90 .88 .88 .86 .83 .85 .86
Aaas
KLA  ATP  ATP+KLA
 NM_153416 achalasia, adrenocortical insufficiency, alacrimia (Aaas), mRNA [NM_153416] KLA .76 .77 .80 .72 .65 .54 .48
ATP 1.04 1.20 .95 1.43 .71 .55 .48
KLA/ATP .85 .88 .67 .96 .58 .58 .47
Acin1
KLA  ATP  ATP+KLA
 AK042374 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630085P16 product:unclassifiable, full insert sequence [AK042374] KLA 1.46 1.17 1.31 1.19 1.06 1.11 .89
ATP .94 1.04 1.35 1.47 1.30 1.55 .65
KLA/ATP 1.22 1.35 1.57 1.74 1.42 1.69 .87
Acin1
KLA  ATP  ATP+KLA
 NM_023190 apoptotic chromatin condensation inducer 1 (Acin1), transcript variant 2, mRNA [NM_023190] KLA 1.22 1.30 1.00 1.27 1.23 1.18 1.03
ATP 1.02 1.04 .94 .99 1.19 1.36 1.08
KLA/ATP 1.16 1.39 1.47 1.35 1.58 1.43 1.13
AF366264
KLA  ATP  ATP+KLA
 NM_153093 cDNA sequence AF366264 (AF366264), mRNA [NM_153093] KLA 1.11 1.05 1.04 1.04 1.06 1.10 1.04
ATP 1.19 1.18 1.15 1.14 1.00 1.15 1.05
KLA/ATP 1.44 1.36 1.49 1.38 1.09 1.31 1.23
AK020140
KLA  ATP  ATP+KLA
 AK020140 12 days embryo male wolffian duct includes surrounding region cDNA, RIKEN full-length enriched library, clone:6720464K01 product:ubiquitin-like 1, full insert sequence. [AK020140] KLA .99 1.05 1.07 1.06 .98 .94 1.06
ATP 1.01 .91 .94 .97 1.03 1.00 1.03
KLA/ATP 1.04 .98 .98 1.08 .96 1.03 1.01
AK030935
KLA  ATP  ATP+KLA
 AK030935 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830463N04 product:unclassifiable, full insert sequence [AK030935] KLA 1.91 1.77 1.68 1.33 1.52 1.15 1.12
ATP 1.32 1.92 1.65 1.60 1.50 1.33 1.16
KLA/ATP 2.19 3.02 2.13 1.95 1.75 1.42 1.31
AK045366
KLA  ATP  ATP+KLA
 AK045366 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230107A03 product:unclassifiable, full insert sequence [AK045366] KLA .88 .80 .79 .86 .89 .97 1.07
ATP 1.21 1.67 2.40 3.50 2.58 1.29 1.12
KLA/ATP .97 .98 1.30 1.76 1.26 1.15 1.06
AU014645
KLA  ATP  ATP+KLA
 NM_001033201 expressed sequence AU014645 (AU014645), mRNA [NM_001033201] KLA .81 .90 .86 .75 .67 .74 .85
ATP 1.01 1.02 1.10 1.08 1.40 1.44 .99
KLA/ATP .83 .85 .89 .80 .81 .99 .73
Bat1a
KLA  ATP  ATP+KLA
 NM_019693 HLA-B-associated transcript 1A (Bat1a), mRNA [NM_019693] KLA 1.15 1.21 1.36 1.17 1.39 1.22 1.07
ATP 1.15 1.27 .91 1.33 1.30 1.23 .92
KLA/ATP 1.41 1.41 .90 1.53 1.07 1.15 1.09
Casc3
KLA  ATP  ATP+KLA
 NM_138660 cancer susceptibility candidate 3 (Casc3), mRNA [NM_138660] KLA .90 .91 1.05 1.13 1.53 1.24 1.24
ATP 1.00 1.00 .81 .81 1.32 1.08 1.01
KLA/ATP .97 .96 .89 .85 1.18 1.13 1.28
Clns1a
KLA  ATP  ATP+KLA
 NM_023671 chloride channel, nucleotide-sensitive, 1A (Clns1a), mRNA [NM_023671] KLA .84 .90 .85 .84 .79 .73 .90
ATP .99 1.04 1.08 1.24 1.00 .81 .93
KLA/ATP .90 .92 .94 1.05 .81 .61 .60
Cyfip1
KLA  ATP  ATP+KLA
 AF072697 SHYC (Shyc) mRNA, complete cds. [AF072697] KLA 1.49 1.21 1.31 2.03 2.22 2.97 2.66
ATP .99 .96 1.08 .89 .74 .90 1.45
KLA/ATP 1.15 1.15 1.65 1.20 .88 .87 3.00
Cyfip1
KLA  ATP  ATP+KLA
 NM_011370 cytoplasmic FMR1 interacting protein 1 (Cyfip1), mRNA [NM_011370] KLA 1.32 1.33 1.49 1.53 1.97 2.66 2.95
ATP 1.00 1.03 .94 .87 .70 .77 1.55
KLA/ATP 1.30 1.35 1.24 1.10 .76 .83 2.61
Cyfip2
KLA  ATP  ATP+KLA
 BC056974 cytoplasmic FMR1 interacting protein 2, mRNA (cDNA clone MGC:66804 IMAGE:6831770), complete cds. [BC056974] KLA 1.07 1.09 1.18 1.18 1.23 1.17 1.61
ATP 1.14 1.46 1.73 1.96 2.02 1.65 1.43
KLA/ATP 1.14 1.26 1.30 1.45 1.30 1.38 2.16
Cyfip2
KLA  ATP  ATP+KLA
 NM_133769 cytoplasmic FMR1 interacting protein 2 (Cyfip2), mRNA [NM_133769] KLA .93 .94 .94 .82 .93 1.16 2.12
ATP 1.18 1.27 .99 1.33 1.46 1.03 1.06
KLA/ATP 1.03 .98 .73 1.09 1.27 1.41 1.68
Ddx20
KLA  ATP  ATP+KLA
 NM_017397 DEAD (Asp-Glu-Ala-Asp) box polypeptide 20 (Ddx20), mRNA [NM_017397] KLA .76 .75 .78 .77 .72 .92 .90
ATP .88 .84 .77 .59 .93 1.10 1.17
KLA/ATP .70 .65 .62 .47 .67 .95 1.05
Eef1a1
KLA  ATP  ATP+KLA
 NM_010106 eukaryotic translation elongation factor 1 alpha 1 (Eef1a1), mRNA [NM_010106] KLA .99 1.05 .96 .85 .88 .67 .57
ATP 1.05 1.05 .97 .96 .94 .82 .56
KLA/ATP .96 .90 .88 .87 .69 .53 .34
Eef1a2
KLA  ATP  ATP+KLA
 NM_007906 eukaryotic translation elongation factor 1 alpha 2 (Eef1a2), mRNA [NM_007906] KLA .96 .97 .92 .99 .88 .80 .87
ATP 1.03 1.13 .98 1.05 .96 .98 1.72
KLA/ATP .95 1.02 .89 1.01 .85 1.27 1.76
Eif1
KLA  ATP  ATP+KLA
 NM_011508 eukaryotic translation initiation factor 1 (Eif1), mRNA [NM_011508] KLA 1.43 1.39 1.34 1.36 1.33 1.01 1.31
ATP 1.10 1.23 1.19 1.46 1.93 2.37 1.25
KLA/ATP 1.41 1.66 1.57 2.08 1.82 2.42 1.63
Eif1a
KLA  ATP  ATP+KLA
 NM_010120 eukaryotic translation initiation factor 1A (Eif1a), mRNA [NM_010120] KLA 2.61 2.56 2.77 2.12 1.70 1.07 1.31
ATP 1.06 1.09 .88 .97 2.35 1.64 1.08
KLA/ATP 2.76 2.81 2.08 2.29 2.77 1.86 .85
Eif1ay
KLA  ATP  ATP+KLA
 AK136814 adult male diencephalon cDNA, RIKEN full-length enriched library, clone:9330022L20 product:eukaryotic translation initiation factor 1A, Y-linked, full insert sequence [AK136814] KLA 1.06 1.18 1.03 .86 .72 .58 .71
ATP 1.08 1.01 1.07 1.02 1.08 .83 .33
KLA/ATP 1.17 1.17 .96 1.00 1.01 .72 .23
Eif1ay
KLA  ATP  ATP+KLA
 NM_025437 eukaryotic translation initiation factor 1A, Y-linked (Eif1ay), mRNA [NM_025437] KLA 1.15 1.08 1.05 1.06 .98 .97 1.21
ATP .90 .89 1.16 1.13 1.06 1.07 .89
KLA/ATP 1.01 1.07 1.27 1.20 1.27 1.04 1.02
Eif1b
KLA  ATP  ATP+KLA
 NM_026892 eukaryotic translation initiation factor 1B (Eif1b), mRNA [NM_026892] KLA .58 .59 .62 .76 .80 .93 1.06
ATP .94 .97 1.22 1.31 1.88 1.79 .87
KLA/ATP .57 .62 .77 .83 1.74 1.65 .83
Eif2b1
KLA  ATP  ATP+KLA
 NM_145371 eukaryotic translation initiation factor 2B, subunit 1 (alpha) (Eif2b1), mRNA [NM_145371] KLA .86 .75 .72 .76 .90 .97 1.11
ATP 1.09 1.15 .89 .95 .71 1.00 1.15
KLA/ATP .72 .80 .81 .83 .62 .78 .72
Eif2b2
KLA  ATP  ATP+KLA
 NM_145445 eukaryotic translation initiation factor 2B, subunit 2 beta (Eif2b2), mRNA [NM_145445] KLA .93 .91 .85 1.14 1.17 1.25 1.36
ATP 1.03 .98 1.02 1.07 1.57 2.02 1.76
KLA/ATP .95 .93 1.05 .92 1.17 2.03 2.73
Eif2b3
KLA  ATP  ATP+KLA
 AK047344 10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930051I16 product:eukaryotic translation initiation factor 2B, subunit 3, full insert sequence. [AK047344] KLA .88 .84 .86 .92 .84 .82 .98
ATP 1.04 .99 .88 .83 .90 .83 .92
KLA/ATP .85 .81 .85 .81 .88 .84 .84
Eif2b4
KLA  ATP  ATP+KLA
 NM_010122 eukaryotic translation initiation factor 2B, subunit 4 delta (Eif2b4), mRNA [NM_010122] KLA .89 .86 .82 .90 .94 1.10 1.14
ATP .99 1.02 .94 1.00 .70 1.18 1.37
KLA/ATP .80 .83 .87 .91 .78 1.09 1.16
Eif2b5
KLA  ATP  ATP+KLA
 NM_172265 eukaryotic translation initiation factor 2B, subunit 5 epsilon (Eif2b5), mRNA [NM_172265] KLA 1.08 1.05 1.12 1.13 1.11 .85 1.15
ATP 1.09 1.15 1.02 1.19 1.01 1.05 1.13
KLA/ATP 1.28 1.35 1.18 1.22 .86 .88 1.06
Eif2s1
KLA  ATP  ATP+KLA
 NM_026114 eukaryotic translation initiation factor 2, subunit 1 alpha (Eif2s1), mRNA [NM_026114] KLA 1.50 1.49 1.52 1.49 1.24 1.12 1.25
ATP 1.00 .98 1.16 1.05 1.03 1.10 .99
KLA/ATP 1.50 1.54 1.73 1.39 1.24 .87 .66
Eif2s2
KLA  ATP  ATP+KLA
 NM_026030 eukaryotic translation initiation factor 2, subunit 2 (beta) (Eif2s2), mRNA [NM_026030] KLA 1.11 1.18 1.07 1.07 1.00 1.17 1.04
ATP .95 .88 1.09 .96 1.55 1.43 .95
KLA/ATP 1.11 1.15 1.16 1.07 1.52 1.49 .85
Eif2s3x
KLA  ATP  ATP+KLA
 AK031304 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030404P13 product:eukaryotic translation initiation factor 2, subunit 3, structural gene X-linked, full insert sequence. [AK031304] KLA .96 .98 1.02 .99 1.02 .94 1.00
ATP 1.03 .93 .99 1.02 .98 .96 1.06
KLA/ATP 1.02 .95 .99 .99 1.05 .99 .99
Eif2s3x
KLA  ATP  ATP+KLA
 NM_012010 eukaryotic translation initiation factor 2, subunit 3, structural gene X-linked (Eif2s3x), mRNA [NM_012010] KLA 1.42 1.56 1.39 1.32 1.13 .84 .96
ATP 1.03 1.10 1.09 1.13 1.07 1.12 1.09
KLA/ATP 1.38 1.56 1.53 1.51 1.14 .85 .83
Eif2s3y
KLA  ATP  ATP+KLA
 NM_012011 eukaryotic translation initiation factor 2, subunit 3, structural gene Y-linked (Eif2s3y), mRNA [NM_012011] KLA 1.37 1.23 1.29 1.62 1.34 1.00 .97
ATP 1.02 .99 1.38 1.12 1.22 1.02 .93
KLA/ATP 1.36 1.33 2.12 1.45 1.28 1.01 1.10
Eif3b
KLA  ATP  ATP+KLA
 NM_133916 eukaryotic translation initiation factor 3, subunit B (Eif3b), mRNA [NM_133916] KLA .97 .98 .93 .88 .80 .73 1.06
ATP 1.10 1.10 1.01 1.11 1.19 1.07 .92
KLA/ATP 1.10 1.06 .93 1.03 .95 .82 .57
Eif3c
KLA  ATP  ATP+KLA
 NM_146200 eukaryotic translation initiation factor 3, subunit C (Eif3c), mRNA [NM_146200] KLA 1.23 1.27 1.10 1.13 1.11 1.01 1.05
ATP 1.08 1.06 1.08 1.06 1.20 1.11 1.05
KLA/ATP 1.22 1.23 1.33 1.20 1.10 .93 .99
Eif3d
KLA  ATP  ATP+KLA
 AK158344 adult inner ear cDNA, RIKEN full-length enriched library, clone:F930105G01 product:eukaryotic translation initiation factor 3, subunit 7 (zeta), full insert sequence [AK158344] KLA .82 .83 .82 .83 .95 .87 1.01
ATP .69 .70 .69 .82 1.11 .86 1.00
KLA/ATP .68 .61 .62 .79 .89 .78 .89
Eif3d
KLA  ATP  ATP+KLA
 NM_018749 eukaryotic translation initiation factor 3, subunit D (Eif3d), mRNA [NM_018749] KLA .96 1.01 .90 .84 .94 .96 1.14
ATP 1.02 1.07 .97 1.05 1.11 1.19 1.00
KLA/ATP .95 1.01 .92 .98 .96 .98 .79
Eif3e
KLA  ATP  ATP+KLA
 NM_008388 eukaryotic translation initiation factor 3, subunit E (Eif3e), mRNA [NM_008388] KLA 1.24 1.29 1.21 1.17 .99 .75 .84
ATP .96 1.02 1.23 1.34 1.05 .77 .49
KLA/ATP 1.13 1.24 1.32 1.46 1.05 .65 .39
Eif3f
KLA  ATP  ATP+KLA
 NM_025344 eukaryotic translation initiation factor 3, subunit F (Eif3f), mRNA [NM_025344] KLA .86 .91 .92 .77 .80 .70 .74
ATP .99 1.10 .91 1.23 1.05 .75 .55
KLA/ATP .98 .96 .71 1.06 .79 .78 .56
Eif3g
KLA  ATP  ATP+KLA
 NM_016876 eukaryotic translation initiation factor 3, subunit G (Eif3g), mRNA [NM_016876] KLA .99 1.03 .89 .80 .65 .65 .89
ATP 1.02 1.02 1.03 .95 1.03 1.08 .88
KLA/ATP 1.06 1.00 .98 .99 .95 .71 .56
Eif3h
KLA  ATP  ATP+KLA
 NM_080635 eukaryotic translation initiation factor 3, subunit H (Eif3h), mRNA [NM_080635] KLA .99 .90 .96 .94 .93 .84 .78
ATP 1.07 1.08 1.01 .94 1.04 .84 .56
KLA/ATP .93 .95 1.23 .94 .88 .71 .52
Eif3i
KLA  ATP  ATP+KLA
 NM_018799 eukaryotic translation initiation factor 3, subunit I (Eif3i), mRNA [NM_018799] KLA 1.06 1.23 1.09 1.05 .95 .86 .87
ATP 1.01 1.11 1.04 1.34 1.21 .86 .63
KLA/ATP 1.19 1.19 1.06 1.47 1.09 .98 .51
Eif3j
KLA  ATP  ATP+KLA
 NM_144545 eukaryotic translation initiation factor 3, subunit J (Eif3j), mRNA [NM_144545] KLA 1.37 1.31 1.06 1.01 .69 .71 1.02
ATP .99 .97 1.34 1.22 1.25 1.31 .85
KLA/ATP 1.27 1.29 1.65 1.41 1.23 .84 .57
Eif3s10
KLA  ATP  ATP+KLA
 NM_010123 eukaryotic translation initiation factor 3, subunit 10 (theta) (Eif3s10), mRNA [NM_010123] KLA .59 .52 .54 .45 .46 .49 .67
ATP 1.19 1.11 1.05 .67 .81 .49 .52
KLA/ATP .63 .55 .49 .33 .44 .36 .22
Eif3s10
KLA  ATP  ATP+KLA
 X17373 gb|M.musculus mRNA for centrosomin A. [X17373] KLA .61 .55 .45 .50 .50 .51 .67
ATP 1.12 .87 .94 .75 1.19 .71 .74
KLA/ATP .64 .55 .57 .39 .73 .37 .36
Eif4a1
KLA  ATP  ATP+KLA
 NM_144958 eukaryotic translation initiation factor 4A1 (Eif4a1), mRNA [NM_144958] KLA .87 .78 .71 .59 .72 .77 .99
ATP .99 1.02 1.11 1.26 1.20 .90 .81
KLA/ATP .81 .77 .76 .98 1.08 .94 .44
Eif4a2
KLA  ATP  ATP+KLA
 NM_013506 eukaryotic translation initiation factor 4A2 (Eif4a2), transcript variant 1, mRNA [NM_013506] KLA .74 .78 .75 .70 .77 .81 1.06
ATP .98 .93 1.00 1.04 1.11 .89 .68
KLA/ATP .72 .71 .86 .78 .87 .77 .52
Eif4a3
KLA  ATP  ATP+KLA
 NM_138669 eukaryotic translation initiation factor 4A, isoform 3 (Eif4a3), mRNA [NM_138669] KLA 1.10 1.12 1.03 1.04 .91 .85 .82
ATP .97 1.05 1.00 1.32 1.02 .89 .72
KLA/ATP 1.07 1.13 1.10 1.37 1.06 .87 .52
Eif4b
KLA  ATP  ATP+KLA
 NM_145625 eukaryotic translation initiation factor 4B (Eif4b), mRNA [NM_145625] KLA .93 .95 .95 .80 .75 .73 .97
ATP 1.08 1.19 1.04 1.43 1.34 1.48 1.04
KLA/ATP 1.13 1.07 .93 1.10 .98 1.19 1.55
Eif4e
KLA  ATP  ATP+KLA
 NM_007917 eukaryotic translation initiation factor 4E (Eif4e), mRNA [NM_007917] KLA 1.22 1.06 .94 .97 .83 .85 1.18
ATP 1.00 1.01 1.27 1.27 2.61 2.08 .97
KLA/ATP .95 1.04 1.37 1.16 1.50 1.28 .73
Eif4e2
KLA  ATP  ATP+KLA
 NM_001039169 eukaryotic translation initiation factor 4E member 2 (Eif4e2), transcript variant 2, mRNA [NM_001039169] KLA 1.53 1.51 1.54 1.52 1.55 1.49 1.55
ATP 1.02 1.08 1.12 1.45 1.61 1.51 1.15
KLA/ATP 1.56 1.60 1.59 1.90 1.90 1.75 1.68
Eif4e2
KLA  ATP  ATP+KLA
 NM_023314 eukaryotic translation initiation factor 4E member 2 (Eif4e2), transcript variant 3, mRNA [NM_023314] KLA 1.42 1.40 1.43 1.35 1.58 1.65 1.42
ATP 1.06 1.06 1.04 .98 1.41 2.07 2.04
KLA/ATP 1.46 1.48 1.40 1.45 1.64 2.12 2.30
Eif4ebp1
KLA  ATP  ATP+KLA
 NM_007918 eukaryotic translation initiation factor 4E binding protein 1 (Eif4ebp1), mRNA [NM_007918] KLA .66 .64 .59 .67 .81 .97 .97
ATP .97 .94 1.10 1.05 1.99 1.60 .91
KLA/ATP .62 .61 .68 .68 1.50 1.24 .95
Eif4g1
KLA  ATP  ATP+KLA
 NM_145941 eukaryotic translation initiation factor 4, gamma 1 (Eif4g1), transcript variant 1, mRNA [NM_145941] KLA 1.14 1.11 1.21 1.05 1.01 .97 1.13
ATP 1.05 1.13 1.02 .94 .91 .96 1.08
KLA/ATP 1.17 1.21 1.03 .95 .77 .80 .88
Eif4g2
KLA  ATP  ATP+KLA
 NM_001040131 eukaryotic translation initiation factor 4, gamma 2 (Eif4g2), transcript variant 2, mRNA [NM_001040131] KLA 2.40 2.29 2.62 2.64 2.99 2.58 1.98
ATP 1.11 1.29 1.03 1.17 1.22 1.42 .90
KLA/ATP 2.25 2.47 1.96 2.07 1.24 1.34 1.14
Eif4g2
KLA  ATP  ATP+KLA
 NM_013507 eukaryotic translation initiation factor 4, gamma 2 (Eif4g2), transcript variant 1, mRNA [NM_013507] KLA 1.75 1.82 2.01 1.93 2.28 1.80 1.75
ATP 1.15 1.25 .94 1.03 1.03 1.03 .73
KLA/ATP 1.86 1.97 1.17 1.35 .91 .95 .95
Eif4g3
KLA  ATP  ATP+KLA
 NM_172703 eukaryotic translation initiation factor 4 gamma, 3 (Eif4g3), mRNA [NM_172703] KLA 1.22 1.10 1.42 1.45 1.56 1.21 1.06
ATP 1.14 1.11 1.06 .99 .82 .81 .91
KLA/ATP 1.25 1.21 1.57 1.30 .87 .72 1.15
Eif5
KLA  ATP  ATP+KLA
 AK051980 12 days embryo eyeball cDNA, RIKEN full-length enriched library, clone:D230030G14 product:unclassifiable, full insert sequence. [AK051980] KLA .85 .80 .72 .84 1.06 .87 .88
ATP 1.20 1.33 3.23 3.61 2.67 1.79 1.14
KLA/ATP .90 .88 2.64 2.70 1.95 1.34 .82
Eif5
KLA  ATP  ATP+KLA
 NM_173363 eukaryotic translation initiation factor 5 (Eif5), transcript variant 1, mRNA [NM_173363] KLA .78 .74 .75 .68 .87 1.03 1.36
ATP .72 .59 .53 .72 1.19 1.90 1.42
KLA/ATP .62 .48 .46 .63 .89 1.26 .96
Eif5b
KLA  ATP  ATP+KLA
 NM_198303 eukaryotic translation initiation factor 5B (Eif5b), mRNA [NM_198303] KLA 1.04 1.08 1.04 1.15 1.13 1.24 1.32
ATP 1.01 .79 .68 .45 1.07 1.40 1.17
KLA/ATP 1.04 1.00 .93 .59 1.58 1.43 1.10
Elac1
KLA  ATP  ATP+KLA
 NM_053255 elaC homolog 1 (E. coli) (Elac1), mRNA [NM_053255] KLA 1.17 1.45 1.39 1.23 1.16 1.14 1.39
ATP 1.00 1.14 .94 .86 .51 .74 1.66
KLA/ATP 1.43 1.49 1.09 .98 .61 .75 1.19
Elac2
KLA  ATP  ATP+KLA
 BC023134 cDNA clone IMAGE:4018447, containing frame-shift errors [BC023134] KLA 1.02 .95 .83 .85 .78 .92 1.05
ATP .87 .85 1.19 .89 .77 .78 .99
KLA/ATP .87 .94 1.05 .81 .68 .51 .43
Elac2
KLA  ATP  ATP+KLA
 NM_023479 elaC homolog 2 (E. coli) (Elac2), mRNA [NM_023479] KLA 1.13 1.19 1.18 1.15 1.12 1.12 1.10
ATP 1.01 1.06 1.10 1.16 1.01 .93 1.04
KLA/ATP 1.24 1.27 1.30 1.16 .95 .80 .72
Fmr1
KLA  ATP  ATP+KLA
 NM_008031 fragile X mental retardation syndrome 1 homolog (Fmr1), mRNA [NM_008031] KLA 2.93 2.70 2.90 2.87 2.07 1.64 1.12
ATP .99 .97 1.32 1.35 1.47 1.31 .93
KLA/ATP 2.61 2.87 3.69 2.66 2.42 1.47 1.33
Fxr1
KLA  ATP  ATP+KLA
 AK004220 18-day embryo whole body cDNA, RIKEN full-length enriched library, clone:1110050J02 product:inferred: fragile X mental retardation gene, autosomal homolog, full insert sequence. [AK004220] KLA 2.26 2.28 2.39 2.38 1.70 1.95 1.43
ATP 1.04 1.09 1.56 1.25 1.31 1.43 .89
KLA/ATP 2.40 2.74 2.74 2.53 2.10 2.07 1.32
Fxr1
KLA  ATP  ATP+KLA
 NM_008053 fragile X mental retardation gene 1, autosomal homolog (Fxr1), transcript variant 3, mRNA [NM_008053] KLA 1.39 1.41 1.44 1.64 1.35 1.34 1.10
ATP .94 .94 1.19 1.11 1.11 1.34 .90
KLA/ATP 1.22 1.51 1.92 1.69 1.89 1.70 1.34
Fxr2
KLA  ATP  ATP+KLA
 NM_011814 fragile X mental retardation, autosomal homolog 2 (Fxr2), mRNA [NM_011814] KLA .97 .93 .96 .85 1.03 1.21 1.24
ATP .97 1.04 .95 1.26 1.70 1.57 1.17
KLA/ATP .98 .95 .95 1.20 1.71 1.60 1.59
Gemin4
KLA  ATP  ATP+KLA
 NM_177367 gem (nuclear organelle) associated protein 4 (Gemin4), mRNA [NM_177367] KLA .49 .48 .48 .43 .47 .52 .70
ATP 1.03 .98 .88 .63 .52 .71 .99
KLA/ATP .52 .50 .50 .44 .44 .56 .46
Gemin5
KLA  ATP  ATP+KLA
 AK162955 adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330083D16 product:gem (nuclear organelle) associated protein 5, full insert sequence. [AK162955] KLA .87 .78 .65 .54 .44 .59 .95
ATP .94 .92 .97 .78 .80 1.16 .69
KLA/ATP .83 .78 .63 .59 .60 .90 .51
Gemin5
KLA  ATP  ATP+KLA
 NM_172558 gem (nuclear organelle) associated protein 5 (Gemin5), mRNA [NM_172558] KLA 1.04 .96 .82 .70 .52 .65 .95
ATP .90 .95 1.10 .95 1.04 1.45 1.08
KLA/ATP 1.11 .98 .88 .88 .73 1.19 .80
Gemin6
KLA  ATP  ATP+KLA
 NM_026053 gem (nuclear organelle) associated protein 6 (Gemin6), mRNA [NM_026053] KLA .97 1.09 .98 1.00 .75 .82 .85
ATP .87 .86 1.05 .83 .46 .47 .50
KLA/ATP .89 .93 1.07 .88 .65 .45 .31
Gemin7
KLA  ATP  ATP+KLA
 NM_027189 gem (nuclear organelle) associated protein 7 (Gemin7), mRNA [NM_027189] KLA 1.57 1.43 1.63 1.63 1.61 1.26 1.00
ATP 1.13 1.07 1.28 .98 .79 1.35 1.32
KLA/ATP 1.53 1.64 2.02 1.73 1.44 1.19 1.35
Gemin8
KLA  ATP  ATP+KLA
 NM_146238 gem (nuclear organelle) associated protein 8 (Gemin8), mRNA [NM_146238] KLA .90 .98 1.06 1.09 .93 .98 1.04
ATP .96 .99 1.16 1.02 .80 .82 1.04
KLA/ATP .98 .94 1.10 1.01 .92 .94 .76
Kpnb1
KLA  ATP  ATP+KLA
 NM_008379 karyopherin (importin) beta 1 (Kpnb1), mRNA [NM_008379] KLA .76 .76 .67 .70 .70 .79 .75
ATP .93 .95 .96 .74 .81 .96 .51
KLA/ATP .68 .70 .70 .55 .66 .58 .42
LOC10004
4696
KLA  ATP  ATP+KLA
 XM_001473268 ref|PREDICTED: Mus musculus similar to cysteine-rich PAK1inhibitor (LOC100044696), mRNA [XM_001473268] KLA .94 .93 .95 .89 .83 .86 .91
ATP .94 .93 .88 .83 .84 .83 .85
KLA/ATP .91 .93 .86 .79 .85 .83 .80
LOC10004
7696
KLA  ATP  ATP+KLA
 XM_001478697 ref|PREDICTED: Mus musculus similar to Eukaryotic translation initiation factor 3, subunit 8 (LOC100047696), mRNA [XM_001478697] KLA 1.43 1.54 1.43 1.33 1.38 1.17 1.10
ATP 1.00 1.04 1.13 1.17 1.16 .92 1.09
KLA/ATP 1.46 1.44 1.51 1.54 1.24 .95 .75
Magoh
KLA  ATP  ATP+KLA
 NM_010760 mago-nashi homolog, proliferation-associated (Drosophila) (Magoh), mRNA [NM_010760] KLA 1.12 1.03 .95 1.10 .90 .96 1.00
ATP .87 .84 1.20 1.06 1.10 1.41 .87
KLA/ATP .93 1.08 1.38 1.10 1.28 1.26 .80
Magohb
KLA  ATP  ATP+KLA
 NM_025564 mago-nashi homolog B (Drosophila) (Magohb), mRNA [NM_025564] KLA 5.18 5.54 4.96 6.10 2.81 2.36 2.86
ATP 1.05 .91 1.21 1.09 .98 1.82 .74
KLA/ATP 5.19 5.26 7.78 5.60 1.78 2.08 1.38
Mm.20466
4
KLA  ATP  ATP+KLA
 149264028 Unknown KLA .94 1.04 1.06 1.04 .99 1.09 .99
ATP 1.00 .87 1.03 1.04 1.02 .92 1.06
KLA/ATP 1.02 1.02 1.03 1.19 1.48 1.09 1.03
Mm.20949
0
KLA  ATP  ATP+KLA
 125628630 Unknown KLA 1.06 1.01 1.07 1.01 1.01 1.00 .95
ATP 1.16 1.09 .89 .91 .68 .76 .87
KLA/ATP 1.03 1.05 .93 .94 .77 .75 .79
Mm.21004
8
KLA  ATP  ATP+KLA
 195963445 Unknown KLA .77 .76 .76 .67 .68 .77 .99
ATP 1.12 .96 .86 .65 .52 .61 .84
KLA/ATP .79 .75 .68 .55 .55 .52 .48
Mm.23522
KLA  ATP  ATP+KLA
 124487357 Unknown KLA 1.02 1.00 .97 .98 1.00 .96 .93
ATP .98 .99 1.06 .97 .94 1.00 1.03
KLA/ATP .94 1.01 1.03 1.01 1.04 1.02 1.01
Mm.24540
KLA  ATP  ATP+KLA
 141801804 Unknown KLA 1.31 1.25 1.32 1.41 1.26 1.20 .94
ATP .94 .95 1.15 .97 .70 1.25 1.29
KLA/ATP 1.18 1.27 1.55 1.35 1.18 1.17 1.30
Mm.28819
4
KLA  ATP  ATP+KLA
 94388003 Unknown KLA .97 .98 .97 1.02 1.04 .97 .87
ATP .97 1.00 .99 1.00 1.02 1.04 1.03
KLA/ATP 1.04 .91 1.05 1.05 .93 .96 1.06
Mm.29002
2
KLA  ATP  ATP+KLA
 167234371 Unknown KLA .53 .50 .44 .38 .36 .39 .57
ATP 1.01 1.07 1.01 1.02 .84 .42 .40
KLA/ATP .53 .51 .38 .41 .47 .40 .21
Mm.32883
1
KLA  ATP  ATP+KLA
 56605679 Unknown KLA 1.26 1.20 1.18 1.36 1.22 1.19 1.03
ATP .85 .78 1.28 1.98 1.39 .88 .81
KLA/ATP 1.03 1.17 1.61 1.59 1.98 1.00 .67
Mm.33624
4
KLA  ATP  ATP+KLA
 158508452 Unknown KLA 1.01 1.08 .97 .96 1.00 .96 .92
ATP .95 .99 .98 .99 .97 1.01 1.03
KLA/ATP .95 .96 1.08 .97 .97 .96 .97
Mm.38910
5
KLA  ATP  ATP+KLA
 94363244 Unknown KLA 1.00 1.05 1.11 1.10 1.05 1.18 1.11
ATP 1.00 1.04 1.07 1.01 1.06 1.06 1.03
KLA/ATP 1.05 .96 1.11 1.18 1.07 1.09 .97
Mm.42395
9
KLA  ATP  ATP+KLA
 159032048 Unknown KLA 1.07 1.11 1.03 1.08 .97 1.08 1.09
ATP .98 1.12 1.05 1.08 1.07 1.12 1.09
KLA/ATP 1.08 1.05 1.18 1.05 1.17 1.11 1.07
Mm.44858
KLA  ATP  ATP+KLA
 124249088 Unknown KLA 1.18 1.32 1.26 1.32 1.35 1.26 1.14
ATP .92 .95 .98 1.09 1.22 1.31 .94
KLA/ATP 1.19 1.30 1.37 1.41 1.47 1.45 1.05
Mm.47379
9
KLA  ATP  ATP+KLA
 142366509 Unknown KLA .90 .91 .87 .75 .81 .94 1.03
ATP .96 1.20 1.11 1.45 1.40 1.24 1.13
KLA/ATP .96 1.03 .89 1.49 1.26 1.31 .99
Ncbp2
KLA  ATP  ATP+KLA
 NM_026554 nuclear cap binding protein subunit 2 (Ncbp2), mRNA [NM_026554] KLA .77 .78 .81 .78 .75 .81 1.04
ATP .93 .93 1.01 1.00 .72 .57 1.15
KLA/ATP .78 .82 .91 .85 .71 .49 .63
Nmd3
KLA  ATP  ATP+KLA
 NM_133787 NMD3 homolog (S. cerevisiae) (Nmd3), mRNA [NM_133787] KLA 1.22 1.22 1.15 .93 .97 1.06 1.22
ATP .98 1.01 .97 .98 1.58 .89 .77
KLA/ATP 1.30 1.20 1.13 1.06 1.25 .80 .65
Nup107
KLA  ATP  ATP+KLA
 NM_134010 nucleoporin 107 (Nup107), mRNA [NM_134010] KLA .55 .52 .49 .48 .43 .48 .48
ATP 1.13 1.16 1.09 1.15 .61 .53 .41
KLA/ATP .51 .57 .55 .70 .58 .58 .33
Nup133
KLA  ATP  ATP+KLA
 NM_172288 nucleoporin 133 (Nup133), mRNA [NM_172288] KLA .70 .66 .66 .71 .51 .47 .48
ATP .98 .94 1.30 .95 .77 .54 .48
KLA/ATP .71 .73 .95 .56 .51 .41 .30
Nup153
KLA  ATP  ATP+KLA
 AK035606 adult male urinary bladder cDNA, RIKEN full-length enriched library, clone:9530076H17 product:unclassifiable, full insert sequence. [AK035606] KLA .99 1.05 .93 .91 1.02 .99 .95
ATP 1.00 .99 1.00 .95 .93 .94 .96
KLA/ATP 1.02 .98 .85 1.04 .96 .86 .85
Nup153
KLA  ATP  ATP+KLA
 NM_175749 nucleoporin 153 (Nup153), mRNA [NM_175749] KLA 1.49 1.46 1.58 1.27 1.05 1.13 1.00
ATP 1.11 1.11 .86 .74 1.31 1.15 .90
KLA/ATP 1.58 1.59 1.21 .99 1.15 1.24 .91
Nup155
KLA  ATP  ATP+KLA
 NM_133227 nucleoporin 155 (Nup155), mRNA [NM_133227] KLA .80 .76 .73 .73 .63 .67 .69
ATP .96 .97 1.46 1.65 1.54 1.81 .61
KLA/ATP .75 .90 2.16 2.30 1.33 2.19 1.40
Nup160
KLA  ATP  ATP+KLA
 NM_021512 nucleoporin 160 (Nup160), mRNA [NM_021512] KLA 1.12 1.15 1.05 .93 .76 .71 .81
ATP 1.04 1.12 1.15 1.04 .91 .88 .65
KLA/ATP 1.14 1.16 1.02 .97 .67 .66 .56
Nup188
KLA  ATP  ATP+KLA
 AK052272 13 days embryo heart cDNA, RIKEN full-length enriched library, clone:D330017D22 product:hypothetical protein, full insert sequence. [AK052272] KLA 1.04 1.03 1.05 1.05 1.03 1.11 1.11
ATP 1.00 1.01 1.01 1.03 1.06 1.01 .93
KLA/ATP 1.08 1.14 .95 1.07 1.05 1.05 .97
Nup188
KLA  ATP  ATP+KLA
 NM_198304 nucleoporin 188 (Nup188), mRNA [NM_198304] KLA .92 .89 .90 .79 .72 .78 .88
ATP 1.08 1.13 .99 1.05 .94 .73 .77
KLA/ATP .94 .99 .84 .85 .72 .68 .55
Nup205
KLA  ATP  ATP+KLA
 AK014419 18 days pregnant adult female placenta and extra embryonic tissue cDNA, RIKEN full-length enriched library, clone:3830404O05 product:hypothetical protein, full insert sequence. [AK014419] KLA 1.13 1.17 1.09 1.20 1.02 .86 .95
ATP .95 .91 1.20 1.02 .93 .98 .99
KLA/ATP 1.16 1.08 1.36 1.15 1.09 .95 .95
Nup205
KLA  ATP  ATP+KLA
 XM_133073 gb|PREDICTED: Mus musculus nucleoporin 205, transcript variant 1 (Nup205), mRNA [XM_133073] KLA 1.07 1.04 1.13 .82 .80 .63 .80
ATP 1.12 1.29 1.00 1.26 .84 .49 .64
KLA/ATP 1.28 1.18 .81 1.12 .76 .46 .46
Nup210
KLA  ATP  ATP+KLA
 NM_018815 nucleoporin 210 (Nup210), mRNA [NM_018815] KLA .74 .72 .66 .58 .51 .39 .25
ATP 1.10 1.05 1.24 1.16 .77 .34 .22
KLA/ATP .77 .73 .79 .63 .54 .36 .23
Nup210l
KLA  ATP  ATP+KLA
 XM_001479463 gb|PREDICTED: Mus musculus nucleoporin 210-like (Nup210l), mRNA [XM_001479463] KLA 1.06 1.06 1.09 1.08 1.12 1.59 1.09
ATP .99 1.06 1.00 1.08 1.19 1.21 .98
KLA/ATP 1.03 1.00 1.10 1.09 1.35 1.79 1.19
Nup214
KLA  ATP  ATP+KLA
 NM_172268 nucleoporin 214 (Nup214), mRNA [NM_172268] KLA .99 .92 .96 .98 .91 1.07 1.09
ATP .96 1.01 1.19 1.15 1.09 1.13 1.01
KLA/ATP .93 1.00 1.12 .97 1.02 1.05 1.14
Nup35
KLA  ATP  ATP+KLA
 NM_027091 nucleoporin 35 (Nup35), mRNA [NM_027091] KLA .43 .42 .40 .45 .45 .54 .58
ATP .96 .93 1.21 1.13 .69 .79 .63
KLA/ATP .41 .40 .46 .40 .36 .56 .59
Nup37
KLA  ATP  ATP+KLA
 NM_028334 nucleoporin 37 (Nup37), mRNA [NM_028334] KLA 1.11 1.03 .96 .96 .82 .73 .70
ATP 1.04 .97 1.09 .76 .58 .66 .64
KLA/ATP .82 .96 1.25 .86 .46 .43 .43
Nup43
KLA  ATP  ATP+KLA
 AK011422 10 days embryo whole body cDNA, RIKEN full-length enriched library, clone:2610016K01 product:OVARC1001161 PROTEIN homolog [Homo sapiens], full insert sequence. [AK011422] KLA .61 .67 .62 .59 .60 .71 .78
ATP .90 .87 1.06 .96 .71 .74 .65
KLA/ATP .63 .63 .73 .65 .65 .66 .57
Nup43
KLA  ATP  ATP+KLA
 NM_145706 nucleoporin 43 (Nup43), mRNA [NM_145706] KLA .52 .50 .55 .45 .42 .56 .58
ATP 1.08 .91 1.13 .92 .60 .60 .48
KLA/ATP .53 .51 .63 .49 .49 .47 .36
Nup50
KLA  ATP  ATP+KLA
 NM_016714 nucleoporin 50 (Nup50), mRNA [NM_016714] KLA .96 .97 1.07 1.15 1.38 1.49 1.51
ATP 1.03 1.05 .96 1.27 2.48 2.30 2.32
KLA/ATP 1.00 1.03 1.02 1.26 2.32 2.54 2.82
Nup54
KLA  ATP  ATP+KLA
 AK014260 13 days embryo head cDNA, RIKEN full-length enriched library, clone:3110079L04 product:similar to 5 of NUCLEOPORIN P54 [Rattus norvegicus], full insert sequence. [AK014260] KLA 1.65 1.49 1.45 1.40 1.06 1.10 1.17
ATP .96 .91 1.17 1.05 1.05 1.15 1.38
KLA/ATP 1.45 1.70 1.67 1.57 1.37 1.18 1.22
Nup54
KLA  ATP  ATP+KLA
 NM_183392 nucleoporin 54 (Nup54), mRNA [NM_183392] KLA 2.25 2.20 1.88 1.22 1.13 1.14 1.32
ATP 1.01 1.12 1.21 1.13 1.52 1.41 1.03
KLA/ATP 2.30 2.37 2.02 1.84 1.46 1.22 1.00
Nup62
KLA  ATP  ATP+KLA
 NM_053074 nucleoporin 62 (Nup62), mRNA [NM_053074] KLA .55 .56 .46 .43 .68 .85 1.09
ATP 1.02 1.04 .73 .73 2.06 1.29 1.60
KLA/ATP .60 .53 .39 .47 1.50 1.45 1.45
Nup85
KLA  ATP  ATP+KLA
 NM_001002929 nucleoporin 85 (Nup85), mRNA [NM_001002929] KLA .42 .41 .34 .31 .24 .30 .35
ATP .92 .85 1.22 .80 .52 .31 .28
KLA/ATP .38 .39 .51 .31 .27 .18 .09
Nup88
KLA  ATP  ATP+KLA
 AK050893 9 days embryo whole body cDNA, RIKEN full-length enriched library, clone:D030031G21 product:preimplantation protein 2, full insert sequence. [AK050893] KLA 1.13 1.22 1.33 1.16 1.29 1.27 1.07
ATP 1.02 1.16 1.22 1.34 1.11 1.20 .90
KLA/ATP 1.18 1.22 1.24 1.44 1.01 1.17 .91
Nup88
KLA  ATP  ATP+KLA
 NM_172394 nucleoporin 88 (Nup88), transcript variant 1, mRNA [NM_172394] KLA .97 .95 .94 1.01 1.00 1.15 .88
ATP .87 .87 1.32 1.12 .93 1.34 .81
KLA/ATP .81 .88 1.29 .89 1.00 1.15 .71
Nup93
KLA  ATP  ATP+KLA
 NM_172410 nucleoporin 93 (Nup93), mRNA [NM_172410] KLA 1.08 1.14 1.21 1.09 1.00 1.08 .85
ATP .94 1.09 1.10 1.11 .80 1.13 .85
KLA/ATP 1.10 1.23 1.24 1.26 .95 1.22 .69
Nup98
KLA  ATP  ATP+KLA
 BC078630 nucleoporin 98, mRNA (cDNA clone IMAGE:30465124), partial cds [BC078630] KLA 3.04 3.20 3.38 3.15 2.46 1.74 1.36
ATP 1.03 1.09 1.24 1.79 2.24 1.79 .98
KLA/ATP 2.92 3.38 3.91 3.93 3.27 2.69 1.67
Nup98
KLA  ATP  ATP+KLA
 NM_022979 nucleoporin 98 (Nup98), mRNA [NM_022979] KLA 2.51 2.59 2.48 1.94 1.54 1.29 1.13
ATP 1.01 1.04 1.17 1.28 1.25 1.39 1.34
KLA/ATP 2.63 2.53 2.27 2.30 1.47 1.48 1.24
Nupl1
KLA  ATP  ATP+KLA
 AK129134 mRNA for mKIAA0410 protein [AK129134] KLA 1.27 1.36 1.37 1.14 1.05 .85 1.05
ATP 1.11 1.24 1.09 1.17 1.19 .78 .74
KLA/ATP 1.50 1.44 1.06 1.20 .67 .67 .56
Nupl1
KLA  ATP  ATP+KLA
 NM_170591 nucleoporin like 1 (Nupl1), mRNA [NM_170591] KLA 1.16 1.25 1.23 1.17 1.01 .90 1.03
ATP 1.05 1.08 1.12 1.23 1.36 1.31 1.00
KLA/ATP 1.40 1.28 1.10 1.38 1.03 1.16 1.13
Nupl2
KLA  ATP  ATP+KLA
 NM_153092 nucleoporin like 2 (Nupl2), mRNA [NM_153092] KLA .86 .91 .86 .84 .78 .86 1.08
ATP 1.06 1.04 .85 .84 .48 .60 1.07
KLA/ATP .92 .93 .77 .76 .60 .59 .73
Nxf1
KLA  ATP  ATP+KLA
 NM_016813 nuclear RNA export factor 1 homolog (S. cerevisiae) (Nxf1), mRNA [NM_016813] KLA 2.56 2.72 2.83 1.97 1.27 1.06 1.10
ATP 1.00 1.13 1.32 2.04 1.64 1.48 1.15
KLA/ATP 2.81 2.91 2.72 4.35 2.42 1.54 1.32
Nxf2
KLA  ATP  ATP+KLA
 NM_031259 nuclear RNA export factor 2 (Nxf2), mRNA [NM_031259] KLA .95 .97 .90 1.00 .91 .90 1.04
ATP 1.04 1.07 .99 1.02 .87 .89 .95
KLA/ATP .94 .89 .88 .95 .85 .90 .85
Nxf3
KLA  ATP  ATP+KLA
 NM_001024141 nuclear RNA export factor 3 (Nxf3), mRNA [NM_001024141] KLA .95 1.03 1.02 1.04 .95 .96 .98
ATP 1.09 .96 1.01 1.01 .95 .96 1.05
KLA/ATP 1.05 1.07 1.08 1.07 .95 1.00 .94
Nxf7
KLA  ATP  ATP+KLA
 NM_130888 nuclear RNA export factor 7 (Nxf7), mRNA [NM_130888] KLA 1.06 .97 .99 1.02 .98 .96 .94
ATP 1.01 1.06 1.04 .95 .99 1.01 .99
KLA/ATP .95 1.01 .97 .95 .94 .93 1.10
Nxt1
KLA  ATP  ATP+KLA
 NM_019761 NTF2-related export protein 1 (Nxt1), transcript variant 2, mRNA [NM_019761] KLA .46 .46 .49 .50 .63 .91 .90
ATP .93 .95 1.08 .96 1.61 3.34 1.02
KLA/ATP .44 .47 .59 .54 1.18 2.80 1.16
Nxt2
KLA  ATP  ATP+KLA
 NM_172782 nuclear transport factor 2-like export factor 2 (Nxt2), mRNA [NM_172782] KLA 1.07 1.12 1.13 1.01 .98 .94 1.01
ATP .98 1.26 1.17 1.44 1.13 .99 .61
KLA/ATP 1.08 1.22 .98 1.32 .97 1.07 .80
Pabpc1
KLA  ATP  ATP+KLA
 AK005009 adult male liver cDNA, RIKEN full-length enriched library, clone:1300015A08 product:poly A binding protein, cytoplasmic 1, full insert sequence [AK005009] KLA 1.13 1.21 1.13 1.02 1.40 1.23 1.50
ATP 1.75 1.90 2.87 2.53 3.50 1.80 1.06
KLA/ATP 1.88 2.43 3.09 2.31 2.25 1.68 1.47
Pabpc1
KLA  ATP  ATP+KLA
 NM_008774 poly A binding protein, cytoplasmic 1 (Pabpc1), mRNA [NM_008774] KLA 1.28 1.27 1.07 1.22 1.13 .99 .92
ATP .99 .91 1.04 .85 1.11 .95 .57
KLA/ATP 1.27 1.10 1.34 1.16 1.13 .82 .78
Pabpc2
KLA  ATP  ATP+KLA
 NM_011033 poly A binding protein, cytoplasmic 2 (Pabpc2), mRNA [NM_011033] KLA 1.24 1.21 1.22 1.20 1.14 .98 .99
ATP 1.00 .98 1.12 1.13 1.24 1.07 .80
KLA/ATP 1.21 1.20 1.37 1.42 1.35 1.17 .96
Pabpc3
KLA  ATP  ATP+KLA
 AK016578 adult male testis cDNA, RIKEN full-length enriched library, clone:4932702K14 product:POLY A BINDING PROTEIN, CYTOPLASMIC 1 homolog [Mus musculus], full insert sequence [AK016578] KLA .99 1.01 .98 1.03 1.04 1.00 .95
ATP .98 1.05 1.00 .98 .98 .99 1.04
KLA/ATP .99 .98 1.01 .96 .94 1.02 1.05
Pabpc4
KLA  ATP  ATP+KLA
 NM_148917 poly A binding protein, cytoplasmic 4 (Pabpc4), transcript variant 2, mRNA [NM_148917] KLA .99 1.01 .91 .75 .56 .45 .55
ATP .99 1.11 1.00 1.32 1.41 1.20 .50
KLA/ATP 1.00 1.03 .80 .96 .84 .74 .49
Pabpc4l
KLA  ATP  ATP+KLA
 NM_001101479 poly(A) binding protein, cytoplasmic 4-like (Pabpc4l), mRNA [NM_001101479] KLA 1.00 1.01 1.02 1.02 .96 .96 .95
ATP 1.03 .95 1.84 1.06 .93 .99 .99
KLA/ATP 1.03 1.00 1.07 1.05 1.00 .93 1.02
Pabpc5
KLA  ATP  ATP+KLA
 NM_053114 poly A binding protein, cytoplasmic 5 (Pabpc5), mRNA [NM_053114] KLA 1.00 1.02 1.03 .99 .95 .96 .97
ATP .95 1.05 .99 .97 1.00 1.03 1.01
KLA/ATP .99 .96 1.00 1.04 .95 .98 1.02
Paip1
KLA  ATP  ATP+KLA
 NM_145457 polyadenylate binding protein-interacting protein 1 (Paip1), transcript variant 1, mRNA [NM_145457] KLA 1.06 1.06 1.06 1.13 1.14 1.20 1.18
ATP 1.00 1.00 1.18 1.10 .95 .79 .84
KLA/ATP 1.03 1.12 1.22 1.06 1.04 .81 .89
Pnn
KLA  ATP  ATP+KLA
 NM_008891 pinin (Pnn), mRNA [NM_008891] KLA .63 .63 .67 .69 .92 1.06 1.11
ATP .76 .74 .62 .57 .72 1.10 .80
KLA/ATP .51 .48 .44 .43 .64 .98 .91
Pom121
KLA  ATP  ATP+KLA
 NM_148932 nuclear pore membrane protein 121 (Pom121), mRNA [NM_148932] KLA 1.04 1.03 1.09 .97 1.14 1.17 1.13
ATP 1.09 1.16 1.04 1.61 1.89 1.48 1.07
KLA/ATP 1.18 1.09 .96 1.35 1.47 1.53 1.20
Pop1
KLA  ATP  ATP+KLA
 AK034063 adult male diencephalon cDNA, RIKEN full-length enriched library, clone:9330153B03 product:RIKEN cDNA 4932434G09 gene, full insert sequence [AK034063] KLA .99 .93 .88 .88 .96 .88 .91
ATP .99 1.04 .88 .82 .87 .92 .97
KLA/ATP .99 .94 .92 .87 .89 .85 .91
Pop1
KLA  ATP  ATP+KLA
 NM_026340 processing of precursor 1, ribonuclease P/MRP family, (S. cerevisiae) (Pop1), transcript variant 2, mRNA [NM_026340] KLA 1.11 1.02 .93 .93 .71 .91 .84
ATP .89 .83 1.18 .94 .96 1.52 1.05
KLA/ATP 1.07 1.04 1.37 .84 .86 .99 .52
Pop1
KLA  ATP  ATP+KLA
 NM_152894 processing of precursor 1, ribonuclease P/MRP family, (S. cerevisiae) (Pop1), transcript variant 1, mRNA [NM_152894] KLA 1.17 1.02 .86 .84 .69 .94 .88
ATP .85 .76 1.15 .76 .83 1.63 1.08
KLA/ATP .94 .94 1.25 .71 .61 1.02 .53
Pop4
KLA  ATP  ATP+KLA
 NM_025390 processing of precursor 4, ribonuclease P/MRP family, (S. cerevisiae) (Pop4), mRNA [NM_025390] KLA 1.73 1.68 1.80 1.63 1.42 1.04 .87
ATP 1.06 .93 .92 .81 .74 1.31 1.05
KLA/ATP 1.72 1.71 1.81 1.56 1.42 1.34 1.22
Pop5
KLA  ATP  ATP+KLA
 NM_026398 processing of precursor 5, ribonuclease P/MRP family (S. cerevisiae) (Pop5), mRNA [NM_026398] KLA .70 .68 .63 .62 .50 .47 .54
ATP .90 .94 1.27 1.26 .91 .70 .77
KLA/ATP .65 .68 .91 .82 .74 .56 .34
Pop7
KLA  ATP  ATP+KLA
 NM_028753 processing of precursor 7, ribonuclease P family, (S. cerevisiae) (Pop7), mRNA [NM_028753] KLA 1.36 1.44 1.36 1.64 1.55 1.18 1.23
ATP .95 .86 .80 .78 1.17 1.61 1.41
KLA/ATP 1.37 1.34 1.33 1.09 1.41 1.83 1.60
Prmt5
KLA  ATP  ATP+KLA
 NM_013768 protein arginine N-methyltransferase 5 (Prmt5), mRNA [NM_013768] KLA .71 .79 .70 .64 .64 .69 .99
ATP .95 1.04 .90 1.01 .63 .69 .93
KLA/ATP .75 .76 .65 .78 .49 .54 .47
Rae1
KLA  ATP  ATP+KLA
 BC060072 RAE1 RNA export 1 homolog (S. pombe), mRNA (cDNA clone MGC:73449 IMAGE:5718934), complete cds [BC060072] KLA 1.00 .98 1.00 .91 .94 .92 .94
ATP 1.21 1.33 .97 .87 1.07 .95 .95
KLA/ATP .99 1.00 .95 .88 1.00 .92 .97
Rae1
KLA  ATP  ATP+KLA
 NM_175112 RAE1 RNA export 1 homolog (S. pombe) (Rae1), mRNA [NM_175112] KLA 1.16 1.12 1.00 1.00 .96 .99 1.01
ATP .89 .80 .64 .62 .90 .98 .99
KLA/ATP 1.06 .95 .77 .69 .77 .90 .80
Ran
KLA  ATP  ATP+KLA
 NM_009391 RAN, member RAS oncogene family (Ran), mRNA [NM_009391] KLA .96 1.03 .96 .88 .78 .61 .75
ATP .96 .96 1.04 .87 1.10 1.18 .64
KLA/ATP .96 .97 .99 .84 1.03 .91 .61
Ranbp2
KLA  ATP  ATP+KLA
 NM_011240 RAN binding protein 2 (Ranbp2), mRNA [NM_011240] KLA 5.10 4.95 5.58 4.41 3.38 2.62 1.07
ATP 1.14 1.16 1.24 .80 1.29 2.73 1.10
KLA/ATP 4.88 5.33 5.97 3.76 3.48 4.54 2.28
Rangap1
KLA  ATP  ATP+KLA
 NM_011241 RAN GTPase activating protein 1 (Rangap1), mRNA [NM_011241] KLA .89 .92 .91 .76 .75 .69 .63
ATP 1.10 1.36 1.01 1.32 1.19 .83 .56
KLA/ATP 1.04 1.08 .90 1.09 .77 .61 .40
Rasl2-9
KLA  ATP  ATP+KLA
 NM_009028 RAS-like, family 2, locus 9 (Rasl2-9), mRNA [NM_009028] KLA .94 1.01 1.05 .89 .81 .62 .70
ATP 1.05 1.05 1.13 .99 1.25 1.24 .68
KLA/ATP 1.00 .98 1.12 .94 1.10 .90 .67
Rbm8a
KLA  ATP  ATP+KLA
 NM_025875 RNA binding motif protein 8a (Rbm8a), transcript variant 2, mRNA [NM_025875] KLA 1.11 1.17 1.05 1.17 1.09 1.08 1.01
ATP 1.00 1.07 1.04 1.17 1.00 1.04 .83
KLA/ATP 1.05 1.13 1.24 1.21 1.18 1.10 .91
Refbp2
KLA  ATP  ATP+KLA
 NM_019484 RNA and export factor binding protein 2 (Refbp2), mRNA [NM_019484] KLA 1.09 1.18 1.13 1.20 1.12 1.09 .84
ATP 1.02 1.07 1.07 1.66 1.44 1.03 .68
KLA/ATP 1.12 1.25 1.19 1.74 1.49 .94 .62
Rnps1
KLA  ATP  ATP+KLA
 NM_009070 ribonucleic acid binding protein S1 (Rnps1), transcript variant 1, mRNA [NM_009070] KLA 1.05 1.02 .93 1.04 .98 1.08 1.05
ATP .89 .92 .95 1.10 1.28 1.32 .85
KLA/ATP .95 1.01 .96 1.22 1.18 1.17 .74
Rnuxa
KLA  ATP  ATP+KLA
 NM_019996 RNA U, small nuclear RNA export adaptor (Rnuxa), mRNA [NM_019996] KLA .80 .81 .84 .85 .87 .96 .95
ATP .97 .91 .84 .70 1.05 1.36 1.24
KLA/ATP .75 .74 .70 .57 .89 1.38 1.12
Rpp14
KLA  ATP  ATP+KLA
 NM_025938 ribonuclease P 14 subunit (human) (Rpp14), mRNA [NM_025938] KLA .81 .84 .70 .73 .65 .79 .90
ATP .94 .79 .93 .57 .49 .69 .71
KLA/ATP .76 .70 .73 .52 .59 .59 .39
Rpp21
KLA  ATP  ATP+KLA
 NM_026308 ribonuclease P 21 subunit (human) (Rpp21), mRNA [NM_026308] KLA .73 .70 .69 .77 .68 .80 .80
ATP .88 .88 1.30 1.27 .94 .85 1.02
KLA/ATP .64 .74 1.01 .98 1.09 .88 .90
Rpp25
KLA  ATP  ATP+KLA
 NM_133982 ribonuclease P 25 subunit (human) (Rpp25), mRNA [NM_133982] KLA .86 .81 .82 .79 .82 .85 .81
ATP .98 1.03 .89 .94 .96 .92 .88
KLA/ATP .85 .83 .84 .80 .78 .95 .84
Rpp30
KLA  ATP  ATP+KLA
 NM_019428 ribonuclease P/MRP 30 subunit (human) (Rpp30), mRNA [NM_019428] KLA 1.13 1.15 1.26 1.48 1.13 .83 1.03
ATP 1.08 .96 1.38 1.17 1.24 1.07 .67
KLA/ATP 1.14 1.18 1.84 1.28 1.40 1.15 .69
Rpp38
KLA  ATP  ATP+KLA
 NM_001013376 ribonuclease P/MRP 38 subunit (human) (Rpp38), mRNA [NM_001013376] KLA .79 .79 .75 .76 .91 .94 1.28
ATP .87 .78 .70 .67 .70 .92 1.69
KLA/ATP .73 .67 .64 .57 .61 .75 .86
Rpp40
KLA  ATP  ATP+KLA
 AK048810 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230071K24 product:similar to RIBONUCLEASE P PROTEIN SUBUNIT P40 (EC 3.1.26.5) (RNASEP PROTEIN P40) (RNASE P SUBUNIT 1) [Homo sapiens], full insert sequence [AK04881 KLA .76 .83 .76 .76 .78 .78 .78
ATP 1.01 .95 .95 .85 .88 .80 1.29
KLA/ATP .84 .80 .77 .76 .78 .79 .75
Rpp40
KLA  ATP  ATP+KLA
 AK048810 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230071K24 product:similar to RIBONUCLEASE P PROTEIN SUBUNIT P40 (EC 3.1.26.5) (RNASEP PROTEIN P40) (RNASE P SUBUNIT 1) [Homo sapiens], full insert sequence [AK048810 KLA .78 .78 .73 .74 .78 .81 .78
ATP .92 .97 1.06 .86 .81 .82 .75
KLA/ATP .73 .75 .80 .71 .70 .73 .74
Rpp40
KLA  ATP  ATP+KLA
 NM_145938 ribonuclease P 40 subunit (human) (Rpp40), mRNA [NM_145938] KLA .73 .72 .65 .64 .55 .52 .89
ATP 1.10 1.04 1.05 .82 .77 .62 .63
KLA/ATP .78 .73 .70 .56 .53 .53 .49
Sap18
KLA  ATP  ATP+KLA
 NM_009119 Sin3-associated polypeptide 18 (Sap18), mRNA [NM_009119] KLA .92 .88 .82 .92 .82 .79 .93
ATP 1.01 1.04 2.82 4.93 2.66 2.06 .87
KLA/ATP .89 .96 2.85 4.52 3.34 2.21 .97
Sec13
KLA  ATP  ATP+KLA
 NM_024206 SEC13 homolog (S. cerevisiae) (Sec13), mRNA [NM_024206] KLA 1.23 1.31 1.29 1.20 1.27 1.27 1.36
ATP 1.00 1.05 1.10 1.27 1.02 .93 1.18
KLA/ATP 1.25 1.37 1.30 1.49 1.10 1.11 .99
Seh1l
KLA  ATP  ATP+KLA
 BC027244 SEH1-like (S. cerevisiae, mRNA (cDNA clone MGC:27929 IMAGE:3584697), complete cds. [BC027244] KLA 1.83 2.09 2.01 1.42 1.03 .89 1.35
ATP 1.09 1.30 .88 1.18 .91 .94 .71
KLA/ATP 2.14 2.16 .97 1.86 .92 .93 .66
Seh1l
KLA  ATP  ATP+KLA
 NM_001039088 SEH1-like (S. cerevisiae (Seh1l), transcript variant 1, mRNA [NM_001039088] KLA 2.49 2.38 2.06 1.77 1.01 .88 1.11
ATP .96 .98 .86 .80 1.06 1.15 .56
KLA/ATP 2.22 2.29 1.76 1.81 1.55 1.15 .44
Seh1l
KLA  ATP  ATP+KLA
 NM_028112 SEH1-like (S. cerevisiae (Seh1l), transcript variant 2, mRNA [NM_028112] KLA 3.12 3.19 3.10 2.32 1.54 1.36 1.61
ATP .95 1.05 1.13 1.15 1.75 2.40 1.29
KLA/ATP 2.97 3.30 3.09 2.91 2.24 2.14 1.44
Senp2
KLA  ATP  ATP+KLA
 AK009212 adult male tongue cDNA, RIKEN full-length enriched library, clone:2310007L05 product:unclassifiable, full insert sequence. [AK009212] KLA .67 .72 .63 .58 .57 .59 .70
ATP .96 .90 .98 .88 .96 .90 .61
KLA/ATP .64 .60 .68 .63 .77 .73 .40
Senp2
KLA  ATP  ATP+KLA
 NM_029457 SUMO/sentrin specific peptidase 2 (Senp2), mRNA [NM_029457] KLA .83 .81 .82 .70 .69 .75 1.19
ATP .98 1.01 .90 1.00 1.09 1.45 1.74
KLA/ATP .85 .85 .68 .75 .67 1.08 1.64
Sip1
KLA  ATP  ATP+KLA
 BC053424 survivor of motor neuron protein interacting protein 1, mRNA (cDNA clone MGC:59266 IMAGE:6336522), complete cds [BC053424] KLA .91 .74 .78 .77 .69 .75 .82
ATP .97 1.05 1.09 .97 .84 .83 .72
KLA/ATP .81 .83 1.01 .86 .75 .71 .67
Sip1
KLA  ATP  ATP+KLA
 NM_025656 survivor of motor neuron protein interacting protein 1 (Sip1), mRNA [NM_025656] KLA .91 .80 .82 .78 .58 .60 .86
ATP .95 .91 1.23 1.10 .71 .76 .86
KLA/ATP .82 .85 1.06 .81 .70 .68 .64
Smn1
KLA  ATP  ATP+KLA
 NM_011420 survival motor neuron 1 (Smn1), mRNA [NM_011420] KLA 1.11 1.17 1.14 1.11 1.15 1.02 1.08
ATP 1.08 1.15 .97 1.33 1.12 1.23 1.02
KLA/ATP 1.27 1.24 .96 1.33 .99 1.12 .95
Snupn
KLA  ATP  ATP+KLA
 NM_178374 snurportin 1 (Snupn), mRNA [NM_178374] KLA 1.18 1.20 1.20 1.12 1.00 1.03 1.16
ATP 1.00 .96 1.05 .92 .63 1.18 1.38
KLA/ATP 1.25 1.24 1.27 1.04 .79 1.00 1.06
Srrm1
KLA  ATP  ATP+KLA
 NM_016799 serine/arginine repetitive matrix 1 (Srrm1), mRNA [NM_016799] KLA 1.10 .94 .98 1.04 1.21 1.29 1.13
ATP 1.03 .81 .96 .88 1.47 1.24 1.10
KLA/ATP 1.27 .93 .90 1.10 1.43 1.25 1.30
Strap
KLA  ATP  ATP+KLA
 NM_011499 serine/threonine kinase receptor associated protein (Strap), mRNA [NM_011499] KLA 1.17 1.22 1.15 1.03 1.06 .97 1.07
ATP .98 1.05 .92 .92 .96 1.09 1.00
KLA/ATP 1.12 1.20 .94 1.01 .81 .78 .78
Sumo1
KLA  ATP  ATP+KLA
 NM_009460 SMT3 suppressor of mif two 3 homolog 1 (yeast) (Sumo1), mRNA [NM_009460] KLA 1.84 1.79 1.98 2.13 1.83 1.49 1.19
ATP .89 .78 1.27 .93 1.09 1.19 .71
KLA/ATP 1.59 1.76 2.63 1.77 2.27 1.45 .87
Sumo2
KLA  ATP  ATP+KLA
 NM_133354 SMT3 suppressor of mif two 3 homolog 2 (yeast) (Sumo2), mRNA [NM_133354] KLA .96 1.08 1.04 .98 .97 .99 1.04
ATP 1.04 1.10 1.10 1.11 1.01 .89 .78
KLA/ATP 1.04 1.02 .91 1.05 .94 .93 .73
Sumo3
KLA  ATP  ATP+KLA
 NM_019929 SMT3 suppressor of mif two 3 homolog 3 (yeast) (Sumo3), mRNA [NM_019929] KLA .64 .66 .72 .62 .79 1.08 1.30
ATP 1.02 1.04 1.06 1.17 1.19 1.03 1.30
KLA/ATP .65 .67 .72 .76 .93 1.21 1.36
Tacc3
KLA  ATP  ATP+KLA
 NM_001040435 transforming, acidic coiled-coil containing protein 3 (Tacc3), mRNA [NM_001040435] KLA .74 .72 .70 .55 .43 .40 .21
ATP 1.11 1.06 1.12 1.27 .93 .50 .17
KLA/ATP .80 .72 .74 .68 .53 .30 .14
Tgs1
KLA  ATP  ATP+KLA
 NM_054089 trimethylguanosine synthase homolog (S. cerevisiae) (Tgs1), mRNA [NM_054089] KLA 2.79 2.82 2.96 2.51 1.69 1.57 1.39
ATP 1.03 1.04 1.03 .86 1.00 1.06 .94
KLA/ATP 3.01 2.97 3.14 2.43 1.97 1.11 .96
Thoc1
KLA  ATP  ATP+KLA
 NM_153552 THO complex 1 (Thoc1), mRNA [NM_153552] KLA 1.22 1.21 1.09 .94 .81 .83 1.06
ATP .93 .92 .95 .85 .79 .90 .82
KLA/ATP 1.12 1.18 1.03 .90 .73 .69 .57
Thoc2
KLA  ATP  ATP+KLA
 AK040892 adult male aorta and vein cDNA, RIKEN full-length enriched library, clone:A530039L08 product:unclassifiable, full insert sequence. [AK040892] KLA 1.63 1.74 1.47 1.52 1.13 1.06 .96
ATP 1.06 1.07 1.24 1.02 1.11 1.31 .77
KLA/ATP 1.67 1.81 1.98 1.28 1.25 1.05 .92
Thoc2
KLA  ATP  ATP+KLA
 NM_001033422 THO complex 2 (Thoc2), mRNA [NM_001033422] KLA 1.67 1.62 1.44 1.46 1.24 1.01 1.00
ATP 1.12 1.12 1.12 1.05 1.20 1.12 .83
KLA/ATP 1.50 1.66 1.78 1.37 1.11 .86 .98
Thoc3
KLA  ATP  ATP+KLA
 NM_028597 THO complex 3 (Thoc3), mRNA [NM_028597] KLA .95 .99 .93 .97 .93 .88 .79
ATP .93 .93 .98 .95 .70 .95 .73
KLA/ATP .88 .97 1.01 .97 .80 .80 .57
Thoc4
KLA  ATP  ATP+KLA
 NM_011568 THO complex 4 (Thoc4), mRNA [NM_011568] KLA .99 .96 .87 .99 .71 .60 .60
ATP .97 .92 1.37 1.52 1.35 1.09 .45
KLA/ATP .92 .98 1.09 1.27 1.31 .85 .29
Thoc5
KLA  ATP  ATP+KLA
 AK040311 0 day neonate thymus cDNA, RIKEN full-length enriched library, clone:A430085L24 product:unclassifiable, full insert sequence [AK040311] KLA .98 .96 1.11 1.02 .98 .96 .98
ATP 1.05 .97 .94 .97 1.25 1.01 1.00
KLA/ATP .95 1.03 .99 .91 .99 1.02 .95
Thoc5
KLA  ATP  ATP+KLA
 NM_172438 THO complex 5 (Thoc5), mRNA [NM_172438] KLA 1.00 1.07 1.12 1.02 1.04 1.07 1.20
ATP 1.08 1.02 .97 1.06 .94 .81 1.09
KLA/ATP 1.19 1.23 .94 1.12 .85 .86 .86
Thoc6
KLA  ATP  ATP+KLA
 NM_001008425 THO complex 6 homolog (Drosophila) (Thoc6), mRNA [NM_001008425] KLA 1.27 1.26 1.27 1.50 1.50 1.26 1.24
ATP .95 1.02 1.13 1.92 1.49 .88 .82
KLA/ATP 1.17 1.25 1.54 1.88 1.68 .92 .76
Thoc7
KLA  ATP  ATP+KLA
 AK005176 adult male cerebellum cDNA, RIKEN full-length enriched library, clone:1500006O09 product:HYPOTHETICAL 23.7 KDA PROTEIN homolog [Homo sapiens], full insert sequence. [AK005176] KLA 1.04 1.01 .93 .95 .73 .65 .69
ATP .89 .85 1.22 1.02 .93 .79 .59
KLA/ATP .93 .95 1.28 1.05 1.06 .64 .42
Thoc7
KLA  ATP  ATP+KLA
 NM_001013578 THO complex 7 homolog (Drosophila) (Thoc7), transcript variant 2, mRNA [NM_001013578] KLA 1.12 1.05 1.07 1.08 .85 .64 .80
ATP 1.11 1.02 1.10 1.14 .97 .63 .58
KLA/ATP 1.08 1.10 1.34 1.07 1.02 .54 .45
Tmem48
KLA  ATP  ATP+KLA
 NM_028355 transmembrane protein 48 (Tmem48), mRNA [NM_028355] KLA .83 .71 .74 .69 .46 .32 .48
ATP 1.03 1.10 1.40 1.25 1.23 1.03 .53
KLA/ATP .90 .75 .94 .75 .55 .49 .30
Tpr
KLA  ATP  ATP+KLA
 NM_133780 translocated promoter region (Tpr), mRNA [NM_133780] KLA 1.86 1.70 1.73 1.84 1.35 1.12 1.05
ATP 1.03 .93 1.16 .85 .90 1.16 .66
KLA/ATP 1.64 1.73 2.44 1.50 1.27 1.00 .83
Trnt1
KLA  ATP  ATP+KLA
 AK010662 ES cells cDNA, RIKEN full-length enriched library, clone:2410043H24 product:tRNA nucleotidyl transferase, CCA-adding, 1, full insert sequence. [AK010662] KLA 1.26 1.42 1.40 1.21 1.13 1.19 1.24
ATP .97 1.03 1.03 .95 .95 1.16 1.13
KLA/ATP 1.27 1.37 1.18 1.11 .90 1.12 1.10
Trnt1
KLA  ATP  ATP+KLA
 NM_027296 tRNA nucleotidyl transferase, CCA-adding, 1 (Trnt1), mRNA [NM_027296] KLA 1.87 1.70 1.59 1.52 1.41 1.38 1.20
ATP 1.09 1.14 .98 .92 1.69 2.07 1.21
KLA/ATP 1.67 1.73 1.81 1.37 1.68 1.82 1.54
Ube2i
KLA  ATP  ATP+KLA
 BC037635 ubiquitin-conjugating enzyme E2I, mRNA (cDNA clone MGC:46871 IMAGE:4951933), complete cds. [BC037635] KLA .79 .80 .78 .82 .95 .90 .98
ATP .96 1.00 .77 .96 1.41 1.01 1.00
KLA/ATP .80 .83 .68 .89 1.03 .93 .79
Ube2i
KLA  ATP  ATP+KLA
 NM_011665 ubiquitin-conjugating enzyme E2I (Ube2i), mRNA [NM_011665] KLA .75 .76 .74 .71 .70 .63 .78
ATP 1.03 1.02 .95 1.02 .93 .66 .75
KLA/ATP .81 .80 .71 .80 .75 .60 .61
Upf1
KLA  ATP  ATP+KLA
 NM_030680 UPF1 regulator of nonsense transcripts homolog (yeast) (Upf1), transcript variant 2, mRNA [NM_030680] KLA 1.04 .97 1.12 1.07 1.34 1.55 1.44
ATP 1.15 1.21 .88 .95 1.05 1.43 1.32
KLA/ATP 1.17 1.20 .92 1.10 1.05 1.33 1.73
Upf2
KLA  ATP  ATP+KLA
 AK045943 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230325K09 product:HYPOTHETICAL 69.8 KDA PROTEIN homolog [Macaca fascicularis], full insert sequence. [AK045943] KLA .95 .97 .96 .91 1.05 1.04 1.06
ATP .96 .92 .92 .94 1.05 1.06 .99
KLA/ATP .88 .93 .90 .91 1.03 .97 1.01
Upf2
KLA  ATP  ATP+KLA
 NM_001081132 UPF2 regulator of nonsense transcripts homolog (yeast) (Upf2), mRNA [NM_001081132] KLA 1.07 1.10 1.08 1.18 1.13 1.36 1.30
ATP .99 1.03 1.11 .85 .96 1.19 1.28
KLA/ATP 1.05 1.18 1.25 .98 1.19 1.41 1.67
Upf3a
KLA  ATP  ATP+KLA
 AK145471 blastocyst blastocyst cDNA, RIKEN full-length enriched library, clone:I1C0002C10 product:UPF3 regulator of nonsense transcripts homolog A (yeast), full insert sequence [AK145471] KLA 1.03 1.11 1.02 1.12 1.04 1.06 .96
ATP .92 .87 1.02 .93 1.04 1.34 .85
KLA/ATP .97 1.05 1.20 1.05 1.27 1.33 .91
Upf3b
KLA  ATP  ATP+KLA
 NM_026573 UPF3 regulator of nonsense transcripts homolog B (yeast) (Upf3b), mRNA [NM_026573] KLA .67 .65 .58 .66 .65 .91 .89
ATP .99 1.11 1.64 1.34 .93 .96 1.02
KLA/ATP .62 .75 .99 .81 .83 .76 .79
Wibg
KLA  ATP  ATP+KLA
 NM_030100 within bgcn homolog (Drosophila) (Wibg), mRNA [NM_030100] KLA 3.31 3.96 3.61 2.82 1.91 1.53 1.21
ATP 1.05 1.30 1.07 1.52 1.46 1.96 .83
KLA/ATP 4.18 4.63 3.16 4.61 2.46 2.21 1.75
Xpo1
KLA  ATP  ATP+KLA
 NM_134014 exportin 1, CRM1 homolog (yeast) (Xpo1), transcript variant 1, mRNA [NM_134014] KLA .85 .84 .92 .94 1.07 1.07 .94
ATP 1.00 .97 .86 .74 .61 .56 .77
KLA/ATP .87 .81 .71 .66 .70 .74 .77
Xpo5
KLA  ATP  ATP+KLA
 BC055455 exportin 5, mRNA (cDNA clone IMAGE:4945665), complete cds. [BC055455] KLA .96 1.02 .93 .94 .96 .97 1.06
ATP 1.04 .94 .98 .96 .96 .95 1.01
KLA/ATP .99 .99 .82 .89 .87 .94 .91
Xpo5
KLA  ATP  ATP+KLA
 BC092371 cDNA clone IMAGE:6844463, containing frame-shift errors [BC092371] KLA .80 .84 .77 .73 .72 .86 .98
ATP 1.07 1.10 .96 .75 .76 .76 .76
KLA/ATP .89 .83 .77 .68 .60 .58 .56
Xpo5
KLA  ATP  ATP+KLA
 NM_028198 exportin 5 (Xpo5), mRNA [NM_028198] KLA 1.02 1.05 1.03 .90 .86 .88 .97
ATP 1.03 1.11 1.05 1.03 .97 1.03 .82
KLA/ATP 1.13 1.05 1.02 .97 .72 .76 .74
Xpot
KLA  ATP  ATP+KLA
 NM_001081056 exportin, tRNA (nuclear export receptor for tRNAs) (Xpot), mRNA [NM_001081056] KLA .69 .64 .58 .52 .65 .98 .87
ATP .89 .82 .78 .54 .68 .73 .82
KLA/ATP .60 .55 .43 .34 .40 .74 1.15